01 3Velexbru
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 39
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 62
2021 Revenue in Millions : 39
Growth (%) : 58
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 68
2022 Revenue in Millions : 62
Growth (%) : 25
LOOKING FOR A SUPPLIER?